Studying nutrition and metabolism in lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial looks at how lung cancer and treatment affect your nutrition and metabolism. It aims to create a personalized nutrition plan for people with lung cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have been diagnosed with lung cancer (non small cell or small cell).
- You are receiving any lung cancer treatment (chemo, immunotherapy, targeted therapy, combined therapy, or no active treatment) as recommended by standard guidelines.
- You do not have any uncontrolled chronic disease or active gastrointestinal disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial follows people with lung nodules over time, using blood and tissue samples to look for metabolic changes that may help understand lung cancer better. If you have a lung nodule found on a CT scan and can safely do lung function tests, this study may be a fit.
This study collects medical information and test results from people with lung cancer that has spread (or cannot be cured with local treatment). It does not test a new drug; it helps researchers better understand patients’ health and care needs over time.
This trial is looking at how well a lung cancer treatment improves survival. It enrolls adults with confirmed lung cancer who can safely take the study medicines and have cancer that can be measured on scans.
This trial studies whether adding special nutrition (oral immunonutrition supplements) can help immunotherapy work better in people with metastatic non-small cell lung cancer. Participants receive immunotherapy, with or without chemotherapy, and must be able to take oral supplements.
This study explores whether a personalized exercise and nutrition program can improve outcomes for people with early-stage NSCLC. If you qualify, you will receive support from a health team and use a device to monitor your progress.
This study looks at how your metabolism (things like blood sugar and cholesterol) might be linked to tumor genes and growth in people with breast cancer. The goal is to find new ways to treat the disease based on your metabolic profile. You may be eligible if you have locally advanced breast cancer (Stage II–III) and are willing to share your medical records.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.